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Dietary supplementation with L-arginine was shown to improve immune responses in various
inﬂammatory models. However, the molecular mechanisms underlying L-arginine effects on
immune cells remain unrecognized. Herein, we tested the hypothesis that a limitation of L-
arginine could lead to the uncoupled state of murine macrophage inducible nitric oxide synthase
and, therefore, increase inducible nitric-oxide-synthase-derived superoxide anion formation.
Importantly, we demonstrated that L-arginine dose- and time dependently potentiated superoxide
anion production in bacterial endotoxin-stimulated macrophages, although it did not inﬂuence
NADPH oxidase expression and activity. Detailed analysis of macrophage activation showed
the time dependence between LPS-induced iNOS expression and increased O2
•− formation.
Moreover, downregulation of macrophage iNOS expression, as well as the inhibition of iNOS
activity by NOS inhibitors, unveiled an important role of this enzyme in controlling O2
•− and
peroxynitrite formation during macrophage stimulation. In conclusion, our data demonstrated that
simultaneous induction of NADPH oxidase, together with the iNOS enzyme, can result in the
uncoupled state of iNOS resulting in the production of functionally important levels of O2
•− soon
after macrophage activation with LPS. Moreover, we demonstrated, for the ﬁrst time that increased
concentrations of L-arginine further potentiate iNOS-dependent O2
•− formation in inﬂammatory
macrophages.
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1. INTRODUCTION
The innate immune system provides the ﬁrst-line defense against injurious insults. Beside its beneﬁcial
role in organism defense, deregulation of innate immune responses is implicated in the pathogenesis of
various chronic diseases, including congestive heart failure, type 2 diabetes, and associated complications
such as dyslipidemia and artherosclerosis [1–4]. These pathological conditions are believed to be tightly
associated with an increased and long-termed synthesis of reactive oxygen (ROS) and reactive nitrogen
species (NO; superoxide anion O2
•−; hydrogen peroxide, H2O2; and peroxynitrite, ONOO−,e t c . )b y
activated monocytes and macrophages. Particularly ROS are suggested to be responsible for the oxidation
of a wide array of molecules in cells, including DNA and proteins that can promote pathological changes in
arteries [1, 3, 4].
O2
•− is the ﬁrst ROS produced by macrophages upon their contact with a variety of activating
stimuli (e.g., LPS, cytokines, growth factors, and fragments of bacterial membranes) [5]. The signiﬁcant
source of O2
•− in phagosomes during the ﬁrst hours after stimulation was shown to be the macrophage
NADPH oxidase enzyme complex [6, 7]. Another crucial reactive intermediate that is critically involved
in the antimicrobial and antitumor activities of macrophages is NO [8]. It is biosynthesized by nitric
oxide synthase (NOS) from L-arginine in macrophages activated by proinﬂammatory stimuli like IFN-
γ,T N F ,a n dL P S[ 8–10]. The enzyme functions as a dimer consisting of two identical monomers,
which can be functionally (and structurally) divided into two major domains: a C-terminal reductase
domain and an N-terminal oxygenase domain. Inducible NOS (iNOS) has been described as calcium-
insensitive and dependent on the binding of different cofactors like NADPH, ﬂavin adenine dinucleotide,
ﬂavin mononuleotide, heme, tetrahydrobiopterine (BH4), and calmodulin [11–13]. Interestingly, it was
shown previously that, in the absence of L-arginine or NOS cofactors, iNOS isolated from macrophages
becomes uncoupled [14, 15]. The uncoupled state of NOS was described when electrons ﬂowing from
the reductase domain to the heme are diverted to molecular oxygen instead of to L-arginine, resulting
in the formation of O2
•− [16]. These facts suggest that simultaneous production of O2
•− (by NADPH
oxidase and iNOS enzyme) and NO (by iNOS enzyme) can lead to increased O2
•− as well as ONOO−
formation. ONOO−, a short-lived oxidant and potent inducer of cell death, is believed to be responsible
for the progress of vascular diseases, ischaemia-reperfusion injury, circulatory shock, and inﬂammation
[1, 2, 5].
L-arginine is an abundant amino acid in body ﬂuids which is not toxic to cells [17]. Importantly, it
was previously demonstrated that L-arginine has a unique role in the maintenance of immune homeostasis
[18, 19]. It was found that it is crucially involved in the regulation of T-cell and macrophage functions [20–
22]andaccordingtodifferentclinicalstudies,itisnowsuggestedthatL-argininesupplementationmaybeof
clinical beneﬁt in improving wound healing and immune responses in humans [23, 24]. Since, L-arginine is
now recognized as inﬂuencing the relationships between innate and acquired immune responses, we tested
the hypothesis that a limitation of L-arginine could lead to the uncoupled state of iNOS and, therefore,
increase iNOS-derived O2
•− formation. The goal was to describe, in greater detail, the effect of various
concentrations of L-arginine on the kinetic of O2
•− and NO production and to ﬁnd the possible connection
between iNOS protein expression and activity and O2
•− production in inﬂammatory macrophages.
2. MATERIAL AND METHODS
2.1. Cell Culture
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (USA). The murine RAW
264.7 macrophage cell line was obtained from the American Type Culture Collection (ATCC, USA) and
was grown in Dulbecco’s modiﬁed Eagle’s media (PAA, Pasching, Austria) supplemented with 10% fetal
bovine serum (FBS, low endotoxin; PAA, Pasching, Austria) and 1% gentamycin. Cells were stimulated
with 50ng/mL of LPS (Escherichia coli serotype 026:B6).
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For the evaluation of the effect of extracellular L-arginine availability, L-arginine-free DMEM media
was used for the experiments. DMEM media was supplemented with different concentrations of L-arginine:
100, 200, 300, and 400μM, which were chosen according to a few criteria. First, we selected doses that
were comparable with reference mammalian plasma values for L-arginine (∼36–140μM) [25], and the
highest concentration of L-arginine (400μM) was comparable with its content in commercially available
DMEM media commonly used for in vitro experiments.
The following NOS inhibitors were employed: N-nitro-L-arginine methyl ester (L-NAME; ﬁnal
concentration 25μM), 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (AMT; ﬁnal concentration 10μM),
aminoguanidine(AG;ﬁnalconcentration10μM),andL-N6-(1-iminoethyl)lysine(LYS;ﬁnalconcentration
10μM).
2.2. Cell Viability
The viability of cells was tested based on the total cellular mass of the adherent cells, using detergent-
compatible protein assay reagent (Bio-Rad Laboratories, USA), with bovine serum albumin as a standard,
as described previously [26]. None of the studied drugs was toxic for RAW 264.7 in the concentrations
applied (data not shown).
2.3. Intracellular L-Arginine Concentration
Intracellular L-arginine was determined using a validated high-throughput liquid chromatography-tandem
mass spectrometry (LC-MS/MS) assay, described in details elsewhere [27]. Cells were treated in DMEM
media without L-arginine or with 400μM of L-arginine in the absence or presence of LPS (50ng/mL) for
24h.
2.4. Western Blot Analysis of iNOS
After the treatment procedure, the RAW 264.7 cells were lysed using SDS-lysing buffer. The same
amount of protein (30μg) from each lysate was subjected to SDS-polyacrylamide gel electrophoresis, as
described previously [28]. After electrophoresis, the proteins were transferred to a PVDF (Immobilon-P)
membrane and then incubated with a mouse iNOS-speciﬁc antibody (1/5000) (Anti-iNOS/NOS Type II
mAb, Transduction Laboratories, USA) for 24h, and with horseradish peroxidase-labelled anti-mouse IgG
antibody (1/2000) (ECL Anti-mouse IgG, Biosciences, USA) for 1h. The equal loading of proteins was
veriﬁed by β-actin immunoblotting (1/5000, SantaCruz Biotechnology, USA). The blots were visualized
using SuperSignal West Pico Chemiluminescent Substrate (Pierce, USA) and exposed to CP-B X-ray ﬁlms
(Agfa, Czech Republic). The relative levels of the proteins were quantiﬁed by scanning densitometry, using
the ImageJ program, and the individual band density value was expressed in arbitrary units.
2.5. Determination of Nitrites
NO production was determined based on the accumulation of NO oxidation product nitrites. Nitrite
accumulation in cell culture media was determined by Griess method, using sodium nitrite as a standard, as
described previously [29].
2.6. Cytochrome c Reduction Assay
The extracellular production of O2
•− in macrophages was determined via spectrophotometric analysis
of cytochrome c reduction as described in details previously [30]. The concentration of superoxide was
calculated using the extinction coefﬁcient of reduced cytochrome c.
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2.7. Determination of NADPH Oxidase Activity
The NADPH oxidase activity was determined in cell lysates prepared according to the well-established
protocol [31]. Brieﬂy, to the 100μL of tested solution, lucigenin was added at ﬁnal concentration 5μM.
After that, NADPH at ﬁnal concentration 100μM was added to start the production of O2
•−.T h e
luminescence signal was measured for 1h.
2.8. Detection of NOX2, p47phox, and p67phox Expression by Quantitative RT-PCR
Total RNA was isolated from RAW 264.7 cells with TRIZOL solution (TRI Reagent RT, MRC, USA),
according to the supplier’s instructions. RNA (1μg) was reverse transcribed to cDNA according to the
manufacturer’s instructions (DyNAmo cDNA Synthesis Kit, Finnzymes, Finland). The primers and probe
no. 20 for NOX2, p67phox, and p47phox were designed using the Universal Probe Library (Roche,
Switzerland). The sequence of primers was as follows: NOX2 (forward 5 -gtgcacagcaaagtgattgg-3 ,r e v e r s e
5 -tgccaacttcctcagctaca-3 ), p47phox (forvard 5 -ctgccacttaaccaggaacat-3 ,r e v e r s e5  -ggacaccttcattcgccata-
3 ), and p67phox (forvard 5 -ccagccattcttcattcaca-3 ,r e v e r s e5  -cccaggtggtagcaatcttc-3 ). Real-time PCR
was performed on RTCykler7300 (Applied Biosystems), and the parameters of ampliﬁcation were set
up according to the supplier’s instructions. The fold of the mRNA induction was calculated using the
  Ct method, with GAPDH as a housekeeping gene (TaqMan Rodent GAPDH Control reagent, Applied
Biosystems, USA) [31].
2.9. Transfection of RAW 264.7 Cells
Using an electroporation system (Gene Pulser II, Bio-Rad laboratopries, USA, for details see [31]), cells
were transfected with plasmids containing the shRNA construct, against iNOS and negative control plasmid
with a scrambled sequence (Origene, USA). Stably transfected cells were grown in DMEM + 5% FBS and
5μg/mL puromycin. RAW 264.7 cells transfected with both shRNA and negative control plasmid were
sensitive to LPS stimulation. In the case of LPS-activated RAW 264.7 cells transfected with negative control
plasmid, the expression of iNOS protein, nitrite accumulation, and O2
•− production were comparable with
those measured for nontransfected LPS-activated RAW 264.7 cells (data not shown).
2.10. Luminol-Enhanced Chemiluminescence (CL) Determination of Oxidative Burst
The CL of macrophages was measured using a microplate luminometer LM-01T (Immunotech, Czech
Republic), as described previously [32]. Brieﬂy, the reaction mixture consisted of 100μL of cells (100×
105), 1mM luminal, and one of the oxidative burst activators (PMA, 97.6μg/mL or opsonized zymosan
particles (OZP), 0.4mg/mL). Spontaneous CL measurements in samples containing the macrophages and
all other substances, but none of the activators, were included in each assay. The CL emission was followed
for 2h at 37◦C. The integral value of the CL reaction represents the total ROS production by macrophages.
2.11. Immunocytochemistry
This method was used for the evaluation of NO- and O2
•−-derived ONOO−, which is known to react
with tyrosine residues on proteins and yields a speciﬁc nitration product, nitrotyrosine [14]. Brieﬂy,
after treatment on 98-well plates (PAA), cells were ﬁxed with 4% of paraformaldehyde in PBS at room
temperature for 30min. Cells were then incubated with mouse monoclonal antinitrotyrosine IgG (1:500,
UpstateBiotechnology,USA)for1h.TheimmunostainingwasaccomplishedwithanExtravidinperoxidase
staining kit using 3-amino-9-ethylcarbazole as a chromogen. The cells were then photographed under a light
microscope at ×200 magniﬁcation.
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2.12. Detection of Scavenging Properties of Drugs against NO
The potential ability of drugs to scavenge NO in chemical systems was tested by the electrochemical
measurement of NO, as described previously [28]. The scavenging properties of the tested drugs are
represented as a very rapid decrease in NO-induced signal detected by electrode connected to ISO NO
MARK II potentiostat (WPI, USA). The integral area under the resulting curve corresponded to the total
amount of NO present in the glass vial and was used for the evaluation of scavenging properties of the
tested drugs. The scavenging properties of the drugs and chemicals against NO were not signiﬁcant (data
not shown).
2.13. Data Analysis
Data were statistically analyzed using a one-way analysis of variance (ANOVA), which was followed by
Dunnett’s multiple comparison test (Statistica for Windows 8.0, Statsoft, Tulsa, Okla, USA). All data are
reported as means ± SEM. A P value of less than 0.05 was considered signiﬁcant.
3. RESULTS
3.1. L-Arginine-Enhanced Production of O2
•− in RAW 264.7 Macrophages
Stimulated with LPS
In the ﬁrst set of experiments, we tested the established hypothesis that a limitation of L-arginine availability
could lead to the uncoupled state of iNOS and, therefore, increase iNOS-derived O2
•− formation.
Surprisingly, we found that, during the time of RAW 264.7 cells incubation with LPS, L-arginine, in all
concentrations used (100–400μM), caused a marked dose- and time-dependent increase in O2
•− formation,
which started to rise after 12h of cell incubation with LPS (Figure 1). In comparison to RAW 264.7
cells incubated in DMEM without L-arginine supplementation, the intracellular concentration of L-arginine
was signiﬁcantly increased after 24h of cell treatment with 400μM of L-arginine (38.91±3.18μMa n d
71.50±3.25μM∗, mean ± SEM), as was determined by the speciﬁc LC-MS/MS method.
3.2. Time-Dependent Induction of iNOS Protein, NO Production, and O2
•− Formation in
LPS-Stimulated RAW 264.7 Cells
The marked increase in O2
•− production in LPS-stimulated macrophages led to questions regarding
the origin of the O2
•− that was produced during the experiments. Therefore, we measured the iNOS
protein expression, nitrite accumulation, and also the O2
•− formation during a time period of 24h after
LPS stimulation of macrophages cultivated in DMEM media with 400μM of L-arginine. As expected,
incubation of RAW 264.7 cells with LPS resulted in a time-dependent accumulation of nitrites and
expression of iNOS protein (Figure 2(a)). The expression of iNOS started approximately 4h after the RAW
264.7cellswerestimulatedwithLPSandwasfollowedbyagradualnitriteaccumulationincellsupernatants
(Figure 2(a)). iNOS expression reached its maximum levels 6h after LPS administration and then remained
stable till the end of the experiment. Interestingly, detailed analysis showed that incubation of RAW 264.7
cells with LPS also resulted in a time-dependent production of O2
•−, which started to rise early (approx.,
3h after LPS administration) and was stable for the next few hours. Then we observed a massive increase
in O2
•− formation (Figure 2(a)). The protein concentration of the total cellular mass had not signiﬁcantly
changed in any of the experimental groups, in comparison with the control cells. This indicates that none of
the studied drugs was toxic for RAW 264.7 in the concentrations applied (data not shown).
3.3. L-Arginine-Enhanced Production of O2
•− Was Not Associated with Changes in
NADPH Oxidase Expression and Activity
Since NADPH oxidase is known to be the principal source of O2
•− in activated phagocytes, we determined
whether the changes in O2
•− production observed during the time of macrophage activation were associated
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FIGURE 1: L-arginine dose- and time-dependently regulated O2
•− production in LPS-stimulated RAW 264.7
cells. Cells were incubated in L-arginine-free DMEM or DMEM with different concentrations of L-arginine
(100, 200, 300, and 400μM) and stimulated with LPS (50ng/mL). The O2
•− was determined in the cell
culture supernatants in indicated times after LPS administration using cytochrome c. Results represent
means ± SEM (n = 6). ∗P < 0.05.
with an increased expression of the selected NADPH oxidase subunits. Using the quantitative RT-PCR
method, we showed that LPS signiﬁcantly increased only the mRNA levels of the NOX2 membrane-
associated complex (Figure 2(b)), with the levels of cytosolic p47 and p67 subunits remaining unaffected
(Figure 2(b)). Importantly, extracellular L-arginine supplementation did not change the mRNA levels of
all subunits in nonstimulated and LPS-stimulated RAW 264.7 cells (Figure 2(b)). To study the activity of
NADPH oxidase in macrophages and cell lysates, we used two known activators of oxidative burst, PMA
and OZP. We found that the PMA- and OZP-induced O2
•− formation was not affected by L-arginine in the
concentrations applied (0–400μM) (data not shown).
3.4. L-Arginine-Enhanced Production of O2
•− Was Dependent on iNOS Expression in RAW
264.7 Macrophages
To further deﬁne the role of iNOS enzyme in the regulation of L-arginine-dependent O2
•− production,
we established stabile RAW 264.7 cell clones transfected with shRNA against iNOS (iNOS−/− RAW
264.7 cells). In contrast to LPS-stimulated RAW 264.7, successfully transfected iNOS−/− RAW 264.7
cells were characterized by downregulated iNOS protein expression (Figure 3(a)). Correspondingly, the
nitrite accumulation in RAW 264.7 cell supernatants was signiﬁcantly higher after 24-hour stimulation with
LPS, in comparison with the basal level of nitrites in nonstimulated RAW 264.7, while no such increase
was observed in iNOS−/− RAW 264.7 cell supernatants. Interestingly, a similar effect was determined
for O2
•− production, which was signiﬁcantly reduced in iNOS−/− RAW 264.7 cells stimulated with LPS
(Figure 3(b)).
Further, we analyzed whether the NADPH oxidase activity in iNOS−/− RAW 264.7 cells can be
affected by the downregulation of iNOS protein expression. We used PMA and OZP for activation of
nonstimulated and LPS-stimulated macrophages in the presence of 400μM L-arginine. We found that
treatment of RAW 264.7 and iNOS−/− RAW 264.7 cells with either PMA or OZP resulted in comparable
changes in O2
•− formation, represented as an increased reduction of cytochrome c (Figures 3(c) and 3(d)).
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FIGURE 2: iNOS protein expression, nitrite accumulation, O2
•− production and expression of mRNA for
NOX2 in RAW 264.7 cells. Cells were incubated in the presence of DMEM media containing 400μM
of L-arginine and stimulated with LPS (50ng/mL). The expression of iNOS protein in cell lysates, the
accumulation of nitrite, and the O2
•− production in cell supernatants (a) were determined at the time points
indicated. Results represent means ± SEM (n = 6). (b) For NOX2, p47, and p67phox expression, cells were
incubated in DMEM media with different concentrations of L-arginine (0, 100, 200, 300, and 400μM) and
stimulated with LPS (50ng/mL) for 4h. Results represent means ± SEM (n = 3). ∗P < 0.05.
However, when RAW 264.7 cells were exposed to LPS for 24h, PMA- and OZP-induced O2
•− production
was signiﬁcantly potentiated, in comparison to iNOS−/− RAW 264.7 cells where no such increase was
observed. Therefore, we concluded that downregulation of iNOS protein expression did not directly
inﬂuence the activation of NADPH oxidase.
Increased NOS-dependent O2
•− formation led to a question of whether the amount of nitrotyrosines
reﬂects the production of ONOO− in macrophages. While LPS-treated RAW 264.7, together with RAW
264.7 cells transfected with the negative control plasmid, showed intensive staining for nitrotyrosines, we
found no effect for iNOS−/− RAW 264.7 cells stimulated with LPS (Figure 4). Interestingly, pretreatment
of LPS-stimulated RAW 264.7 cells with L-NAME (25μM) led to a remarkable decrease in the
immunostaining for nitrotyrosines (Figure 4(c)).
3.5. NOS Inhibitors Regulate NO and O2
•− Production in LPS-Stimulated
RAW 264.7 Macrophages
To verify our hypothesis that an increase in O2
•− formation was associated with the activity of the iNOS
enzyme, we used different NOS inhibitors (AMT, 10μM; AG, 10μM; L-NAME, 25μM; LYS, 10μM).
None of the studied drugs was toxic for RAW 264.7 in the concentrations applied (data not shown). First, we
tested the effects of inhibitors on iNOS protein expression and iNOS-derived NO production for 24h. The
exposure of LPS-stimulated RAW 264.7 cells to AMT, AG, L-NAME, and LYS caused a signiﬁcant inhibi-
tion of nitrite formation in cell supernatants, while iNOS protein expression was not changed (Figure 5(a)).
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FIGURE 3: iNOS protein expression, nitrite accumulation, and O2
•− production in RAW 264.7 and iNOS−/−
RAW 264.7 cells. Macrophages were stably transfected with shRNA against iNOS and then stimulated with
LPS (50ng/mL). RAW 264.7 and iNOS−/− RAW 264.7 cells were incubated in DMEM media containing
400μM of L-arginine. iNOS protein expression in cell lysates, accumulation of nitrite (a), and O2
•−
production in cell supernatants (b) were determined using methods described in Section 2 (n = 6). The
O2
•− production was also potentate using (c) PMA and (d) OZP with or without co-administration of LPS
(50ng/mL) (n = 6). ∗P < 0.05.
In control experiments, we found that none of the NOS inhibitors tested were able to induce iNOS protein
expression or nitrite accumulation in nonstimulated RAW 264.7 cells incubated in the presence of 400μM
L-arginine (data not shown).
To conﬁrm that O2
•− was generated by iNOS, cells were pretreated with NOS inhibitors in the two
time-points chosen, according to the results shown in Figure 2. NOS inhibitors administered together with
LPS had no effect on O2
•− production within the ﬁrst 10h of incubation (Figure 5(b)). In contrast, after
15h of incubation, more than 70% of O2
•− production was blocked by all of the NOS inhibitors used
(Figure 5(b)). Furthermore, the NOS inhibitors did not affect NADPH-oxidase-derived O2
•− production in
PMA- or OZP-activated RAW 264.7 cells incubated with 400μM L-arginine in the absence of LPS (data
not shown).
2450TheScientiﬁcWorldJOURNAL (2011) 11, 2443–2457
(a)
(b)
(c)
(d)
(e)
(f)
FIGURE 4: Nitrotyrosine formation in (a) RAW 264.7 cells, (b) RAW 264.7 cells stimulated with LPS, (c)
LPS-stimulated RAW 264.7 cells treated with L-NAME (25μM), (d) iNOS−/− RAW 264.7 cells, (e) iNOS−/−
RAW 264.7 cells stimulated with LPS, and (f) RAW 264.7 cells transfected with negative control plasmid
stimulated with LPS. Cells were incubated in the presence of DMEM media supplemented with 400μMo f
L-arginine.
3.6. BH4 Is Able to Suppress L-Arginine-Induced NO and O2
•− Production in
RAW 264.7 Cells
According to data published by Kuzkaya et al. [33], we expected that the uncoupled state of iNOS induced
by increased extracellular L-arginine concentrations in LPS-stimulated RAW 264.7 cells could be caused
by the decreasing levels of BH4 during the time of the experiments. We added an additional 10μMo fB H 4
to the cultured media with 400μM L-arginine, along with LPS (50ng/mL) stimulation. We showed that the
treatment of RAW 264.7 cells with BH4 had no effect on nitrite accumulation and O2
•− production after
10h of incubation with LPS (data not shown); however, it was able to partially prevent a massive increase in
O2
•− production after 24h of incubation with LPS (Figure 6). Accordingly, treatment of RAW 264.7 cells
with BH4 caused an increase in nitrite accumulation after 24h of cell incubation with LPS, and the iNOS
protein expression remained unaffected (Figure 6).
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FIGURE 5: NOS inhibitors-dependent regulation of LPS-induced nitrite accumulation and O2
•− production
in RAW 264.7 cells stimulated by LPS. Cells were pretreated with NOS inhibitors at the indicated
concentrations in the presence of DMEM media containing 400μM of L-arginine. (a) The LPS-induced
iNOS protein expression and nitrite accumulation were determined after 24h of cell incubation (n = 6). (b)
The O2
•− production was measured in the presence of DMEM media containing 400μM of L-arginine in
two time points: 10 and 15h after LPS administration (n = 6). ∗P < 0.05.
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FIGURE 6: Effect of BH4 on iNOS protein expression, nitrite accumulation, and O2
•− production in RAW
264.7 cells. Cells were incubated with one of the essential NOS cofactors, BH4 in the presence of DMEM
media containing 400μM of L-arginine. iNOS protein expression in cell lysates, accumulation of nitrite
(a), and O2
•− production in cell supernatants (b) were determined after 24h of cell incubation with LPS
(50ng/mL). Results represent means ± SEM (n = 3). ∗P < 0.05.
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4. DISCUSSION
The current data clearly demonstrate that, beside the regulation of NO production, L-arginine is able to
cause a dose- and time-dependent increase in iNOS-derived O2
•− formation in inﬂammatory macrophages.
Our ﬁndings are important with respect to the fact that activation and/or accumulation of macrophages can
signiﬁcantly contribute to the development of inﬂammation, as well as many disease states that have been
shown to be associated with impaired L-arginine metabolism and reduced L-arginine plasma levels (e.g.,
asthma, pulmonary hypertension, cytstic ﬁbrosis, and renal failure) [34–39].
At present, NADPH oxidase is still considered the main source of O2
•− in inﬂammatory
macrophages [7]. Importantly, it was demonstrated previously that iNOS derived from macrophages is
capable of generating functionally important levels of O2
•−, in addition to NO generation under conditions
of L-arginine or cofactors depletion [14, 15]. In contrast, we demonstrated that downregulation of iNOS
protein expression leads to a marked reduction of O2
•− production in LPS-stimulated macrophages which
are exposed to 400μM of extracellular L-arginine. We found that, under inﬂammatory conditions, the
activity of iNOS enzyme signiﬁcantly contributes to O2
•− production after 15 hours of incubation of the
macrophages with LPS. Importantly, O2
•− production was potentiated by an increased extracellular L-
arginineconcentration.Fromtheseobservations,severalquestionsarise.(a)IstheincreasedO2
•− formation
associated with changes in NADPH-oxidase expression or activity? (b) Is there any time consistency
between O2
•− formation, iNOS protein expression, and iNOS-dependent NO production? (c) Is iNOS
probably responsible for increased O2
•− formation?
According to our presented data, we came up with the following possible explanations. First,
the NOS inhibitors used in this study could have scavenging properties against ROS and NO. This
explanation can be refused, because no scavenging properties of the NOS inhibitors were found in our
study. The second alternative is that NOS inhibitors or L-arginine alone may regulate the NADPH oxidase-
dependent production of O2
•−. However, we demonstrated that none of the tested compounds affected
O2
•− production from NADPH oxidase in macrophages activated with PMA or OZP in the absence of
LPS. The third possibility, that L-arginine regulated the expression of NADPH oxidase in LPS-stimulated
macrophages, was also disproved, because the treatment of RAW 264.7 cells with a different extracellular
L-arginine concentration had no effect on the NOX2, p47, and p67 mRNA levels. Finally, after the series of
experiments with iNOS−/− RAW 264.7 macrophages and NOS inhibitors, we proved our assumption that
the massive increase in O2
•− formation was very likely caused by macrophage iNOS “uncoupling.”
As demonstrated by our study, increased L-arginine concentrations actively contribute to the
uncoupled state of iNOS. In contrast, Xia et al. [14, 15], in both of their studies, presented that a depletion
of cytosolic L-arginine triggered O2
•− generation from macrophage iNOS. Xia et al. [14] also showed that
increased O2
•− production can be followed by an NOS-dependent ONOO− formation. They suggest that by
coupling L-arginine levels to iNOS protein synthesis, macrophages provide a mechanism for ensuring that
iNOS is not expressed in L-arginine-depleted cells and that toxic O2
•− cannot be produced. Based on these
data, other clinical studies suggested that limited L-arginine levels can be the signiﬁcant source of O2
•−-a s
well as ONOO−-mediated tissue injury [34, 36, 37, 40]. Compared to our results, there arises an important
question regarding the possibility that the lack of L-arginine is responsible for the macrophage ONOO−
formation. Our data and data published by others [41, 42] implicate that when L-arginine is not available
for the iNOS, there is no NO production in stimulated macrophages and thus NO cannot react with O2
•− to
form ONOO−. Therefore, it is questionable if iNOS-derived ONOO− can be responsible for the increased
nitrotyrosine formation in macrophages activated in L-arginine-free media as demonstrated by Xia et al.
[14, 15]. Further, Xia et al. [14] did not detect O2
•− production by macrophages incubated with LPS and
IFN-γ inthepresenceofL-argininesupplementedmediaafter24h.Incontrast,inourexperiments,theLPS-
induced O2
•− formation could be detected by at least two different methodological approaches as presented
above. Interestingly, the only difference between our study and study of Xia et al. [14, 15] is costimulation
of macrophages by IFN-γ. The combination of LPS and IFN-γ was used for macrophage stimulation
by other authors evaluating O2
•− and ONOO− production by macrophages [42, 43]. Amatore et al. [42]
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described that NO production between 8–18h after cell stimulation was slight, and a strong linear increase
was then observed for a period of 18–48. Similarly in our experiments, the beginning of gradual NO
production was detected after 6h of macrophage incubation with LPS. Further, Amatore et al. [42]
discovered that macrophages produced ONOO− after 18h of incubation with both stimulators, which is
in accordance with our data.
We suggest that, during the time of macrophage activation with LPS, L-arginine is consumed by
iNOS enzyme, resulting in the production of NO. Because NADPH oxidase in macrophages produces a
relevant amount of O2
•− during the ﬁrst hours after stimulation with LPS, it can easily react with iNOS-
derived NO and form highly reactive ONOO−. The more L-arginine that is present, the more ONOO− that
is produced. Because ONOO− is a powerful oxidant, it is able to readily oxidize BH4, which can lead to
the formation of the BH3
• radical. This phenomenon was already described in endothelial culture cells
and vessels, where these conditions caused eNOS uncoupling. Interestingly, after exposure of endothelial
cells to ONOO−, eNOS activity could be fully restored by treating the cells with exogenous BH4 [33]. Our
hypothesis that the same conditions might play an important role in iNOS uncoupling was supported by the
fact that supplementation of BH4 to the cultured and LPS-stimulated macrophages partially prevented an
increase in O2
•− formation after prolonged incubation with LPS.
Our ﬁndings have some important implications. We have shown that LPS is able to biphasically
induce O2
•− production in RAW 264.7 cells. In the ﬁrst few hours after LPS-stimulation, macrophages
produce a relatively small but signiﬁcant amounts of O2
•− which should be considered as being formed
by activated NADPH oxidase. In the second phase, LPS causes a massive increase in O2
•− production,
predominantly due to iNOS uncoupling. More importantly, the second phase of O2
•− production is directly
controlled by extracellular L-arginine availability.
In conclusion, the L-arginine availability seems to play a critical role for the immune state of
macrophages and there are now two sides of this problematic. One is that a lack of extracellular L-
arginine is responsible for the attenuation of immune functions associated with the decrease in immune
cell proliferation and NO production, which can lead to different pathophysiological states [44–48]. On the
other side, supplementation by L-arginine could lead to an increased O2
•−, and subsequently an increased
ONOO formation that is critical for host defense but might also be deleterious for host cells/tissue.
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